Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05691062

Titanium vs. PEEK Fusion Devices in 1 Level TLIF

A Prospective, Randomized Comparison of Titanium vs. PEEK Fusion Devices in 1 Level TLIF

Status
Enrolling By Invitation
Phase
Phase 4
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Twin Cities Spine Center · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate and follow the clinical and radiographic outcomes of patients undergoing 1 level TLIF randomized to either a titanium or a PEEK spacer to 24 months after surgery.

Detailed description

Transforaminal lumbar interbody fusion (TLIF) remains a common surgical technique for the management of lumbar spondylosis requiring decompression and fusion. The choice of interbody spacer remains dependent on surgeon preference with a variety of options available for use. Two of the most commonly used interbody spacers are made of polyetheretherketone (PEEK) and titanium.1 While both spacers have produced reliable rates of fusion with good clinical outcomes, debate remains as to which interbody spacer is superior. Proponents of PEEK argue that it is radiolucent and has an elastic modulus similar to bone thus decreasing rates of subsidence. However, PEEK is a hydrophobic material that does not integrate with bone. Titanium on the other hand demonstrates osseointegration and may lead to increased rates of fusion.While there are retrospective studies available comparing the two materials, the studies are small and there is a paucity of prospective data comparing the radiographic and clinical outcomes of these spacers. Given the frequency with which these spacers are used, it is important to determine which spacer produces better clinical and radiographic outcomes for patients.

Conditions

Interventions

TypeNameDescription
DEVICETitanium Fusion DeviceTitanium fusion device will be utilized for one-level lumbar fusion.
DEVICEPEEK Fusion DevicePEEK fusion device will be utilized for one-level lumbar fusion.

Timeline

Start date
2024-09-01
Primary completion
2027-01-11
Completion
2028-01-11
First posted
2023-01-19
Last updated
2025-06-24

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05691062. Inclusion in this directory is not an endorsement.